Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
2002
n/a
LTM Revenue $292M
LTM EBITDA $35.1M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
SonoScape has a last 12-month revenue of $292M and a last 12-month EBITDA of $35.1M.
In the most recent fiscal year, SonoScape achieved revenue of $277M and an EBITDA of $29.3M.
SonoScape expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See SonoScape valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $292M | $277M | XXX | XXX | XXX |
Gross Profit | $162M | $203M | XXX | XXX | XXX |
Gross Margin | 56% | 73% | XXX | XXX | XXX |
EBITDA | $75.1M | $29.3M | XXX | XXX | XXX |
EBITDA Margin | 26% | 11% | XXX | XXX | XXX |
Net Profit | $51.0M | $62.6M | XXX | XXX | XXX |
Net Margin | 17% | 23% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, SonoScape's stock price is CNY 31 (or $4).
SonoScape has current market cap of CNY 13.4B (or $1.8B), and EV of CNY 11.8B (or $1.6B).
See SonoScape trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.6B | $1.8B | XXX | XXX | XXX | XXX | $0.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, SonoScape has market cap of $1.8B and EV of $1.6B.
SonoScape's trades at 5.6x LTM EV/Revenue multiple, and 46.2x LTM EBITDA.
Analysts estimate SonoScape's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for SonoScape and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.6B | XXX | XXX | XXX |
EV/Revenue | 5.8x | XXX | XXX | XXX |
EV/EBITDA | 55.3x | XXX | XXX | XXX |
P/E | 94.2x | XXX | XXX | XXX |
P/E/Growth | 1.1x | XXX | XXX | XXX |
EV/FCF | 117.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSonoScape's NTM/LTM revenue growth is 18%
SonoScape's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, SonoScape's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate SonoScape's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for SonoScape and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -5% | XXX | XXX | XXX | XXX |
EBITDA Margin | 11% | XXX | XXX | XXX | XXX |
EBITDA Growth | -61% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 28% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 23% | XXX | XXX | XXX | XXX |
Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SonoScape acquired XXX companies to date.
Last acquisition by SonoScape was XXXXXXXX, XXXXX XXXXX XXXXXX . SonoScape acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was SonoScape founded? | SonoScape was founded in 2002. |
Where is SonoScape headquartered? | SonoScape is headquartered in China. |
Is SonoScape publicy listed? | Yes, SonoScape is a public company listed on SHE. |
What is the stock symbol of SonoScape? | SonoScape trades under 300633 ticker. |
When did SonoScape go public? | SonoScape went public in 2017. |
Who are competitors of SonoScape? | Similar companies to SonoScape include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of SonoScape? | SonoScape's current market cap is $1.8B |
What is the current revenue of SonoScape? | SonoScape's last 12-month revenue is $292M. |
What is the current EBITDA of SonoScape? | SonoScape's last 12-month EBITDA is $35.1M. |
What is the current EV/Revenue multiple of SonoScape? | Current revenue multiple of SonoScape is 5.6x. |
What is the current EV/EBITDA multiple of SonoScape? | Current EBITDA multiple of SonoScape is 46.2x. |
What is the current revenue growth of SonoScape? | SonoScape revenue growth between 2023 and 2024 was -5%. |
Is SonoScape profitable? | Yes, SonoScape is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.